- Home
- KNSA vs ACT Comparison
KNSA vs ACT Comparison
Compare KNSA & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | ACT |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 6.3B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KNSA | ACT |
|---|---|---|
| Price | $94.47 | $46.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | ★ $109.43 | $47.20 |
| AVG Volume (30 Days) | ★ 925.9K | 410.2K |
| Earning Date | 10-27-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 2.01% |
| EPS Growth | ★ 225.00 | 3.43 |
| EPS | 1.14 | ★ 3.57 |
| Revenue | $677,564,000.00 | ★ $1,235,827,000.00 |
| Revenue This Year | $54.96 | $2.53 |
| Revenue Next Year | $24.16 | $1.36 |
| P/E Ratio | $84.32 | ★ $19.93 |
| Revenue Growth | ★ 60.09 | 2.83 |
| 52 Week Low | $37.02 | $36.65 |
| 52 Week High | $98.48 | $50.56 |
Technical Indicators
Market Signals| Indicator | KNSA | ACT |
|---|---|---|
| Relative Strength Index (RSI) | 60.03 | 46.49 |
| Support Level | $72.76 | $46.29 |
| Resistance Level | $98.48 | $46.78 |
| Average True Range (ATR) | 5.49 | 1.27 |
| MACD | 0.78 | 0.05 |
| Stochastic Oscillator | 84.57 | 28.39 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The company operates in a single reportable segment namely Mortgage Insurance The principal mortgage insurance customers are originators of residential mortgage loans that determines the mortgage insurer or insurers to be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.